☆ 4.4 Article

Answers to common questions about COVID-19 vaccines in children with cancer

PEDIATRIC BLOOD & CANCER (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study

Julia M. Gumy et al.

Summary: This study aims to understand global caregiver concerns about SARS-CoV-2 vaccination for children with cancer and provide guidance for healthcare providers. A survey was conducted and the findings revealed caregivers' primary concerns regarding side effects and vaccine safety. Logistics-related questions were of concern for caregivers in low- and middle-income countries. Efforts are needed to provide tailored information and reduce global inequities in accessing vaccines.

PEDIATRIC HEMATOLOGY AND ONCOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants

David W. Eyre et al.

Summary: In this study, it was found that vaccination reduces the transmission risk of the Delta variant, but the protection of the vaccine decreases over time. The effectiveness of the vaccine is higher against the Alpha variant compared to the Delta variant.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

E. B. Walter et al.

Summary: A regimen of two 10-mu g doses of BNT162b2 administered 21 days apart was found to be safe, immunogenic, and efficacious in children aged 5 to 11 years.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement

Eliska Furlong et al.

Summary: The Australian Technical Advisory Group on Immunisation and New Zealand Ministry of Health recommend COVID-19 vaccination for children and adolescents aged >= 5 years with cancer and immunocompromising non-malignant haematological conditions, as they are at increased risk of severe COVID-19. The efficacy and safety of mRNA COVID-19 vaccines in this population need further investigation.

MEDICAL JOURNAL OF AUSTRALIA (2022)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

C. Buddy Creech et al.

Summary: The study demonstrated that two 50-mu g doses of the mRNA-1273 vaccine are safe and effective in inducing immune responses and preventing Covid-19 in children aged 6 to 11 years, with noninferior responses compared to young adults.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology Oncology

Simone Cesaro et al.

Summary: This consensus document aims to support the Italian pediatric hematological oncological centers in scientifically correct communication with families and patients, and to promote vaccination for pediatric oncohematological patients. The document highlights the importance of vaccination in preventing COVID-19 and enabling regular treatments for children and adolescents affected by hematological and oncological diseases. All statements were approved.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Review Pediatrics

COVID-19 review shows that benefits of vaccinating children and adolescents appear to outweigh risks of post-vaccination myopericarditis

Rosa Morello et al.

Summary: Post-vaccination myopericarditis after COVID-19 vaccination is a serious adverse event in children over 5 years of age. Boys in their mid-teens are more commonly affected. Treatment involves the use of non-steroidal anti-inflammatory drugs, and patients require cardiac follow-up and should avoid physical activity.

ACTA PAEDIATRICA (2022)

添加到收藏夹

Article Medicine, General & Internal

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

J. Sadoff et al.

Summary: The study conducted a multicenter, placebo-controlled, phase 1-2a trial, with participants randomly assigned to receive the Ad26.COV2.S vaccine. The results showed that the safety and immunogenicity profiles of the vaccine support further development.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Immunology

Evaluation of COVID-19 Vaccine Refusal in Parents

Metin Yigit et al.

Summary: The study found that a majority of parents were hesitant about COVID-19 vaccines, especially towards foreign vaccines. Factors such as education level and anxiety about COVID-19 infection were found to be associated with vaccine acceptance among parents.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

添加到收藏夹

Article Oncology

SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities

Emily E. Johnston et al.

Summary: The study investigated 917 children aged 21 and under who were receiving cancer therapy and infected with SARS-CoV-2, with a higher proportion of Hispanics and publicly insured patients represented in the cohort. Most patients were symptomatic, with 31.2% requiring hospitalization, 10.9% needing respiratory support, 9.2% admitted to the ICU, and 1.6% died due to SARS-CoV-2.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study

Sheena Mukkada et al.

Summary: The study found that around one fifth of children and adolescents with cancer infected with SARS-CoV-2 developed severe or critical illness, with a higher death rate than in the general pediatric population. Factors associated with treatment modification were different from those associated with disease severity, highlighting the need to raise global awareness of the high risk of severe COVID-19 illness in children and adolescents with cancer. These findings could inform clinical guidelines and improve care practices for this vulnerable population.

LANCET ONCOLOGY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries

Malia Skjefte et al.

Summary: The study found that COVID-19 vaccine acceptance among pregnant women and mothers of young children varied globally, with higher acceptance rates in India, the Philippines, and Latin American countries, and lower rates in Russia, the United States, and Australia. The main predictors of vaccine acceptance included confidence in vaccine safety and effectiveness, concern about COVID-19, trust in public health agencies, adherence to mask guidelines, and attitudes towards routine vaccines.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

添加到收藏夹

Review Oncology

COVID-19 vaccines for patients with cancer: benefits likely outweigh risks

Joyce K. Hwang et al.

Summary: Within less than a year of the COVID-19 pandemic, ten vaccines for SARS-CoV-2 have been approved, with two mRNA-based vaccines showing promising results. Concerns arise about the safety and efficacy of these vaccines for cancer patients undergoing immunomodulatory treatments, but most cancer therapies should not hinder the generation of protective immunity. Additional research in this area is needed and it is recommended that the majority of cancer patients receive COVID vaccinations when possible.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

添加到收藏夹

Article Immunology

Risk Factors for Severe COVID-19 in Children

Kelly Graff et al.

Summary: This study found that extremes of age, comorbid conditions, and elevated CRP are predictors of severe COVID-19 disease in children. These findings can help pediatric providers and public health officials tailor clinical management and resource allocation strategies more effectively.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Individual and social determinants of COVID-19 vaccine uptake

K. Viswanath et al.

Summary: Our study identified race/ethnicity, risk perceptions, exposure to different media for COVID-19 news, party identification and confidence in scientists as factors that would be affecting COVID-19 vaccine uptake. The good news is that these are addressable through strategic public health communications, but a lot of work remains to be done with some urgency.

BMC PUBLIC HEALTH (2021)

添加到收藏夹

Article Oncology

Cocooning Against COVID-19: The Argument for Vaccinating Caregivers of Patients With Cancer

Maresa C. Woodfield et al.

Summary: It is suggested that cocoon vaccination strategies should be used to protect cancer patients in the COVID-19 vaccination race. Medical systems specializing in cancer care should support education and vaccination campaigns targeting informal caregivers and household contacts, in addition to cancer patients.

CANCER (2021)

添加到收藏夹

Article Oncology

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Aakash Desai et al.

Summary: The rapid development of COVID-19 vaccines has provided new hope of mitigating the disease, and it is necessary to prioritize cancer patients, including those participating in oncology clinical trials, for vaccination. Data on the safety, tolerability and efficacy of the vaccines in patients with cancer are currently limited, but the benefits of vaccination are likely to far outweigh the risks of adverse events.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Nicole Doria-Rose et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Oncology

Seroconversion rates following COVID-19 vaccination among patients with cancer

Astha Thakkar et al.

Summary: Most cancer patients show high seroconversion rates after receiving COVID-19 vaccines, but those with hematologic malignancies, especially after highly immunosuppressive therapies, exhibit lower conversion rates. Patients on immune checkpoint inhibitor therapy or hormonal therapy display high conversion rates.

CANCER CELL (2021)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents

Kashif Ali et al.

Summary: The study demonstrates that the mRNA-1273 vaccine has good safety profile in adolescents aged 12 to 17 years, with immune response similar to that in young adults. It also proves the efficacy of the vaccine in preventing Covid-19 in this age group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Robert W. Frenck et al.

Summary: The BNT162b2 vaccine showed favorable safety profile and a greater immune response in 12-to-15-year-old recipients compared to young adults, and demonstrated high effectiveness against Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Environmental Sciences

Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging

Amanda Hudson et al.

Summary: Determinants of vaccine hesitancy include demographic factors such as age, income, education, health literacy, rurality, and parental status, as well as individual difference factors like mistrust in authority, disgust sensitivity, and risk aversion. Public health communications must employ a range of strategies to address these factors and increase public confidence in available COVID-19 vaccines.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

Julia W. Gargano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Review Hematology

Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients

Abi Vijenthira et al.

Summary: The study found that patients receiving anti-CD20 therapy have poor responses to all types of vaccines, especially during treatment and at least 6 months post-treatment, with significantly lower SC rates compared to healthy and disease control groups. As time progresses, response to vaccination gradually improves, but even 12 months post-therapy, it may not reach the level of healthy controls.

BLOOD ADVANCES (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation

Robert M. Jacobson et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Immunology

Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England

Sadie Bell et al.

VACCINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Household Transmission of SARS-CoV-2 A Systematic Review and Meta-analysis

Zachary J. Madewell et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Immunology

Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey

Ran D. Goldman et al.

VACCINE (2020)

添加到收藏夹

Article Communication

Preparing for A COVID-19 Vaccine: A Mixed Methods Study of Vaccine Hesitant Parents

Matthew E. Rhodes et al.

JOURNAL OF HEALTH COMMUNICATION (2020)

添加到收藏夹

Article Pediatrics

Parental Acceptability of COVID-19 Vaccination for Children Under the Age of 18 Years: Cross-Sectional Online Survey

Ke Chun Zhang et al.

JMIR PEDIATRICS AND PARENTING (2020)

添加到收藏夹

Article Immunology

Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial

Matteo Mombelli et al.

VACCINE (2018)

添加到收藏夹

Article Immunology

A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients

Yoichiro Natori et al.

CLINICAL INFECTIOUS DISEASES (2018)

添加到收藏夹

Review Immunology

Strategies for addressing vaccine hesitancy - A systematic review

Caitlin Jarrett et al.

VACCINE (2015)

添加到收藏夹

Article Immunology

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Lorry G. Rubin et al.

CLINICAL INFECTIOUS DISEASES (2014)

添加到收藏夹

Article Oncology

Does school attendance during initial cancer treatment in childhood increase the risk of infection?

Margareta af Sandeberg et al.

PEDIATRIC BLOOD & CANCER (2013)

添加到收藏夹

Review Infectious Diseases

Vaccination of immunocompromised patients

Per Ljungman

CLINICAL MICROBIOLOGY AND INFECTION (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.